Articles
Hypertension
h 
Enhanced sympathetic nervous system activity: the linchpin between
insulin resistance, hyperinsulinemia, and heart rate
(Oct 96 AJH)
h
"Inappropriate" physician habits in prescribing oral nifedipine
capsules in hospitalized patients
(Oct 96 AJH)
h
Racial differences in plasma endothelin-1 concentrations in
individuals with essential hypertension
(Oct 96 HYP)
h
Should a moratorium be placed on sublingual nifedipine capsules given
for hypertensive emergencies and pseudoemergencies?
(Oct 96 JAMA)
h
Diagnosis of renovascular disease by intra- and extrarenal Doppler
scanning
(Oct 96 KI)
h 
Erectile dysfunction in hypertensive subjects
(Nov 96 HYP)
h
New staging system of JNC-V alters assessment of the severity and
treatment of hypertension
(NOv 96 HYP)
h
Enigma of fetal/infant-origins hypothesis
(Nov 96 LANCET)
h
Preeclampsia -- A state of sympathetic overactivity
(Nov 96 NEJM)
h 
Exaggerated blood pressure response to maximal exercise in endurance-
trained individuals
(Dec 96 AJH)
h
Body mass index is associated with differential seasonal change in
ambulatory blood pressure levels
(Dec 96 AJH)
h
Increased accumulation of tissue ACE in human atherosclerotic
coronary artery disease
(Dec 96 CIRC)
h
Double-blind, placebo-controlled study of the effects of carvedilol in
patients with moderate to severe heart failure
(Dec 96 CIRC)
h
Effect of diuretic-based antihypertensive treatment on
cardiovascular disease risk in older diabetic patients with
isolated systolic hypertension
(Dec 96 JAMA)
Dialysis, Chronic Renal Failure
d
The safety of intravenous iron dextran in hemodialysis patients
(Oct 96 AJKD)
d
Impact of the initial levels of laboratory variables on
survival in chronic dialysis patients
(Oct 96 AJKD)
d
A prospective randomized control study of oral nystatin prophylaxis
for Candida peritonitis complicating continuous ambulatory
peritoneal dialysis
(Oct 96 AJKD)
d
Prevalence and risk factors for osteopenia in dialysis patients
(Oct 96 AJKD)
d
Secondary hyperparathyroidism complicated by parathyromatosis
(Oct 96 AJKD)
d
Randomized cross-over study of adverse reactions and cost implications of
intravenous push compared with infusion of iron dextran in
hemodialysis patients
(Oct 96 AJKD)
d
Vision, hearing loss after use of markedly outdated cellulose acetate
dialyzers
(Oct 96 CDC)
d
Predictors of type of vascular access in hemodialysis patients
(Oct 96 JAMA)
d
Nine episodes of CPD-associated peritonitis with vancomycin
resistant enterococci
(Oct 96 KI)
d
Effects of different membranes and dialysis technologies on patient
treatment tolerance and nutritional parameters
(Oct 96 KI)
d
Relationship of ambulatory blood pressure monitoring data to
echocardiographic findings in haemodialysis patients
(Oct 96 NDT)
d
Brief report. Colchicine toxicity in patients with chronic renal
failure
(Oct 96 NDT)
d
Pruritus and skin hydration during dialysis
(Oct 96 NDT)
d
The influence of small solute clearance on dietary protein
intake in CAPD patients: a methodologic analysis based on cross-sectional
and prospective studies
(Oct 96 AJKD)
d
Screening for extreme postdialysis urea rebound using the Smye method:
Patients with access recirculation identified when a slow flow method
is not used to draw the postdialysis blood
(Nov 96 AJKD)
d
Use of low-dose, low molecular weight heparin in hemodialysis
(Nov 96 AJKD)
d
Dialysis in rats with acute renal failure: evaluation of three
different dialyzer membranes
(Nov 96 AO)
d
Effect of subcutaneous tunneling on internal jugular catheter-
related sepsis in critically ill patients
(Nov 96 JAMA)
d
A clustering of epidural abscesses in chronic hemodialysis patients:
risk of salvaging access catheters
(Oct 96 JASN)
d
HIV-1 survival kinetics in peritoneal dialysis effluent
(Nov 96 KI)
d
Predictors of stroke in patients receiving chronic hemodialysis
(Nov 96 KI)
d
Alternative puncture site of implantable permanent hemodialysis
catheters
(Nov 96 NDT)
d
Erythrocyte sedimentation rate, an underestimated tool in chronic
renal failure
(Nov 96 NDT)
d
Creatinine determination in peritoneal dialysis: what method should be
used?
(Nov 96 NDT)
d
An unexpected pregnancy causes poor drainage in automated
peritoneal dialysis
(Nov 96 NDT)
d
Subclinical pulmonary edema and intermittent hemodialysis
(Nov 96 NDT)
d
Spontaneous tendon ruptures in patients on chronic dialysis
(Dec 96 AJKD)
d
Effect of apheresis of low-density lipoprotein on peripheral
vascular disease in hypercholesterolemic patients with coronary artery
disease
(Dec 96 AIM)
d
Effect of iron status on intestinal absorption of aluminum: a
reappraisal
(Dec 96 KI)
d
Nutritional and prognostic correlates of bioimpedance indices
in hemodialysis patients
(Dec 96 KI)
d
Vancomycin-dependent Enterococcus faecalis
(Dec 96 LANCET)
d
Randomised crossover trial of naltrexone in uraemic pruritus
(Dec 96 LANCET)
d
Survival in long-term hemodialysis patients: results from the annual
survey of the Japanese Society for Dialysis Therapy
(Nov 96 NDT)
d
Is it worth performing kidney replacement therapy on patients over
80?
(Dec 96 NDT)
d
Peritoneal dialysis-related peritonitis treatment recommendations:
1996 update
(Dec 96 PDI)
d
Body surface area limitations in achieving adequate therapy in
peritoneal dialysis patients
(Dec 96 PDI)
d
Gram-negative peritonitis in peritoneal dialysis: improved outcome
with intraperitoneal ceftazidime
(Dec 96 PDI)
Clinical Nephrology
c
Effect of bicarbonate administration on plasma potassium in dialysis
patients: interactions with insulin and albuterol
(Oct 96 AJKD)
c
Histopathology of renal posttransplant lymphoproliferation: comparison
with rejection using the Banff Schema
(Oct 96 AJKD)
c
Significance of the Banff borderline biopsy
(Oct 96 AJKD)
c
An economic analysis of captopril in the treatment of diabetic
nephropaty
(Oct 96 DC)
c
A clinical approach for the diagnosis of diabetes mellitus: An
analysis using glycosylated hemoglobin levels
(Oct 96 JAMA)
c
Plasma homocysteine as a risk factor for atheroembolic events in
systemic lupus erythematosus
(Oct 96 LANCET)
c
A familial syndrome of hypocalcemia with hypercalciuria due to
mutations in the calcium-sensing receptor
(Oct 96 NEJM)
c
Fish oil in diabetic nephropathy
(Nov 96 DC)
c
Lifetime benefits and costs of intensive therapy as practiced in the
diabetes control and complications trial
(Nov 96 JAMA)
c
Magic mushrooms: hope for a 'cheap high' resulting in end-stage renal
failure
(Nov 96 NDT)
c
Acute on chronic renal failure induced by simvastatin
(Nov 96 NDT)
c
Long-term outome of adult-onset minimal-change nephropathy
(Nov 96 NDT)
c
Development and progression of renal disease in Pima Indians with
non-insulin-dependent diabetes mellitus
(Nov 96 NEJM)
c
Prevalence and clinical associations of anti-cardiolipin antibodies in
a large inception cohort of patients with connective tissue diseases
(Dec 96 AJM)
c
Calcium and vitamin D3 supplementation prevents bone loss in the spine
secondary to low-dose corticosteroids in patients with rheumatoid
arthritis
(Dec 96 AIM)
c
Acute cyclosporine-induced nephrotoxicity in renal transplant
recipients: The role of the transplanted kidney
(Dec 96 JASN)
c
Revision of diagnostic criteria for diabetes
(Dec 96 LANCET)
c
Successful long-term treatment of post-transplant erythrocytosis with
losartan
(Dec 96 NDT)
c
Hyponatremic renal pseudofailure -- don't forget the possibility of
uroperitoneum
(Dec 96 NDT)
Use back arrow on your browser to go back to HDCN home page (faster)
or click on the arrow.